Establishment Labs (ESTA) stock drops 5.5% — what to watch before Monday’s open and JPM conference
Establishment Labs shares fell 5.5% to $68.84 Friday, underperforming a flat Nasdaq. The company recently submitted its Motiva implants to the FDA for breast reconstruction approval. Management will present at the J.P. Morgan Healthcare Conference on Jan. 14. Establishment Labs posted a 2024 net loss of about $85 million on $166 million in revenue.